A small molecule with larger-than-expected effects on hepatitis B virus
Cell Host & Microbe · 2026
DOI: 10.1016/j.chom.2025.12.013 ↗Kurz gefasst
Kommentar in der Zeitschrift Cell Host & Microbe, 2026. Verfasst von Ashwin Balagopal und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Johns Hopkins University School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Hepatitis B virus, Antiviral Agents, Hepatitis B, Chronic, Immunologic Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Chronic hepatitis B virus (HBV) affects ∼250 million people worldwide. Functional cure is difficult to achieve with existing medications. In this issue, Fernandes et al. developed a double-humanized chronic HBV murine model to test the capsid assembly modulator GLP-26. GLP-26 reduced blood HBV DNA and surface antigen and induced immunomodulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- The Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: acox@jhmi.edu.
Zitieren
APA
Balagopal, A., & Cox, A. L. (2026). A small molecule with larger-than-expected effects on hepatitis B virus. Cell Host & Microbe. https://doi.org/10.1016/j.chom.2025.12.013
Vancouver
Balagopal A, Cox AL. A small molecule with larger-than-expected effects on hepatitis B virus. Cell Host & Microbe. 2026. doi:10.1016/j.chom.2025.12.013
BibTeX
@article{Balagopal2026,
author = {Balagopal, Ashwin and Cox, Andrea L},
title = {A small molecule with larger-than-expected effects on hepatitis B virus},
journal = {Cell Host & Microbe},
year = {2026},
doi = {10.1016/j.chom.2025.12.013}
}
EUVIMED